A lifestyle magazine for the Hudson Valley and Catskills with the latest news on arts and cultural events, new restaurants, ...

Amid a $130 million renovation, Jersey City’s historic Loew’s Jersey Theatre is still on track to open in fall 2026, ...

The neonatal Fc receptor (FcRn)-targeted antibody enters an increasingly crowded gMG market, but J&J expects that as the ... 4.70 points on nipocalimab versus 3.25 points on placebo, researchers ...

As of April 25, the company was still running a phase 3 follow-up study for patients in the initial late-stage trial. Bota-vec was originally developed by J&J’s Janssen unit in collaboration ...

Anne J. Hudson, age 81, beloved wife of the late Joseph ... Visitation Tuesday, April 22nd 3:00 pm to 8:00 pm at Modell Funeral Home, 7710 S. Cass Ave, Darien. Funeral Service Wednesday, April ...

Samantha DiGeorge is happy to be right where she’s supposed to be — in a theater. “The past few years I’ve been surviving,” she says. “The past three weeks I’ve actually been living.” ...

You’ll never catch Jennifer Hudson in a pair of low-rise jeans. On a segment called “In-fit or Out-fit” during a recent episode of “The Jennifer Hudson Show,” the host, 43, made her ...

The White House Correspondents’ Association on Monday pushed back against the White House’s plans to exert control over the briefing room seating assignments for journalists. In an email to ...

In October of last year, J&J revealed its plan to spend more than $2 billion to build the facility, which will create more than 500 jobs and will produce treatments for cancer, immunology and ...

With the golf course playing just about two strokes over par on average, it was J.J. Spaun who stood tall in ... The wiry right hander played his first 13 holes in 3 under to reach 11 under ...

After leading Minnesota to a 14-3 regular ... round selection, J.J. McCarthy, is currently expected to take over the offense. Here's a look at the Vikings' quarterback depth chart, what to know ...

Johnson & Johnson has added to the opioid kappa blues. Months after Neumora reported a phase 3 flop, J&J has stopped development of its rival drug candidate aticaprant as an adjunctive treatment ...